Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0513 Transporter Info | ||||
Gene Name | KCNQ1 | ||||
Transporter Name | Voltage-gated potassium channel Kv7.1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Colon; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of KCNQ1 gene in melanoma condition | [4] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of KCNQ1 gene in melanoma condition, which leads to an increased expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
MXI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Max-interacting protein 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-interacting protein 1 (MXI1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in glioblastoma multiforme condition | [6] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of KCNQ1 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [7] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of KCNQ1 gene in . condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the KCNQ1 gene in prostate cancer condition, which affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon2 |
Binding to KCNQ1 gene in . condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of KCNQ1 gene in . condition, which leads to a affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon3 |
Binding to KCNQ1 gene in prostate cancer condition | [10] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of KCNQ1 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in health condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of KCNQ1 gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
PGR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Progesterone receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Progesterone receptor (PGR) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to bind to the transcription of KCNQ1 gene in megakaryocytes condition, which leads to a affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon2 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
GATA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of KCNQ1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon2 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in gastric cancer condition | [13] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to bind to the transcription of KCNQ1 gene in gastric cancer condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of KCNQ1 gene in gastric cancer condition | [13] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of KCNQ1 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
CTCFL |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Transcriptional repressor CTCFL | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCFL (CTCFL) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in erythroleukemia condition | [14] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of KCNQ1 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
ZNF92 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Zinc finger protein 92 | Transcription Factor Info | ||||
Tissue |
Retina | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 92 (ZNF92) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PBX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in health condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of KCNQ1 gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ELF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
ETV1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
ETS translocation variant 1 | Transcription Factor Info | ||||
Tissue |
Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS translocation variant 1 (ETV1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of KCNQ1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon2 |
Direct binding to KCNQ1 gene | [2] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
SPI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in K562 cells | [15] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of KCNQ1 gene in K562 cells, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Transcriptional Phenomenon2 |
Direct binding to KCNQ1 gene | [5] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of KCNQ1 gene in colorectal cancer condition | [16] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of KCNQ1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT5A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
Signal transducer and activator of transcription 5A | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Signal transducer and activator of transcription 5A (STAT5A) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in health condition | [17] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of KCNQ1 gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TP73 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of KCNQ1 gene in osteosarcoma condition | [18] | ||||
TF Protein Name |
Tumor protein p73 | Transcription Factor Info | ||||
Studied Phenotype |
Osteosarcoma [ICD11: 2B51] | |||||
Tissue |
Bone | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human osteosarcoma cells (U2OS) | |||||
Detailed Description |
Tumor protein p73 (TP73) has been reported to activate the transcription of KCNQ1 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to KCNQ1 gene in megakaryocytes condition | [12] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of KCNQ1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [1] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Brain; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
Class8.1: TATA-binding proteins |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TBP |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to KCNQ1 gene | [3] | ||||
TF Protein Name |
TATA-box-binding protein | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
TATA-box-binding protein (TBP) can directly bind to the KCNQ1 gene, which in turn affects the expression or function of the drug transporter Voltage-gated potassium channel Kv7.1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.